Differential impact of impaired fasting glucose versus impaired glucose tolerance on cardiometabolic risk factors in multi-ethnic overweight/obese children

被引:0
作者
Mariska van Vliet
Roel P. Gazendam
Inès A. von Rosenstiel
Anton P. van Zanten
Desiderius P. M. Brandjes
Jos H. Beijnen
Joost Rotteveel
Michaela Diamant
机构
[1] Slotervaart Hospital,Department of Paediatrics
[2] Slotervaart Hospital,Department Pharmacy and Pharmacology
[3] Slotervaart Hospital,Department of Internal Medicine
[4] Slotervaart Hospital,Department of Clinical Chemistry
[5] VU University Medical Centre,Department of Internal Medicine, Diabetes Centre
[6] VU University Medical Centre,Department of Paediatrics
来源
European Journal of Pediatrics | 2011年 / 170卷
关键词
Obesity; Metabolic syndrome X; Children; Adolescents; Glucose metabolism disorders;
D O I
暂无
中图分类号
学科分类号
摘要
We aimed to investigate the prevalence of impaired fasting glucose (IFG) and impaired glucose tolerance (IGT), and their associations with cardiometabolic risk factors, according to ethnicity in a large obese paediatric cohort. A 75-g oral glucose tolerance test was performed in 1,007 overweight/obese Dutch children of multi-ethnic origin, referred to the obesity outpatient clinics of two Dutch hospitals in Amsterdam (mean age, 11.4 ± 3.2 years; 50.7% boys). Anthropometric parameters and blood samples were collected, and cardiometabolic risk factors were assessed. The cohort consisted of Dutch native (26.0%), Turkish (23.7%), Moroccan (18.8%) and children of ‘other’ (31.5%) ethnicity. The prevalence of IFG was significantly higher in Moroccan and Turkish children as compared to Dutch native children (25.4% and 19.7% vs. 11.8%, respectively, P < 0.05). IGT was most frequently present in Turkish and Dutch native children, relative to Moroccan children (6.3% and 5.3% vs. 1.6%, P < 0.05). Besides pubertal status and ethnicity, components of ‘metabolic syndrome’ (MetS) which were associated with IGT, independent of hyperinsulinaemia, were hypertension [odds ratio (OR), 2.3; 95% CI, 1.1–4.9] while a trend was seen for high triglycerides (OR, 2.0; 95% CI, 0.9–4.3). When analyzing components of MetS which were associated with IFG, only low high-density lipoprotein cholesterol was significantly associated (OR, 1.7; 95% CI, 1.2–2.5) independent of hyperinsulinaemia. In conclusion, in a Dutch multi-ethnic cohort of overweight/obese children, a high prevalence of IFG was found against a low prevalence of IGT, which differed in their associations with cardiometabolic risk factors.
引用
收藏
页码:589 / 597
页数:8
相关论文
共 101 条
  • [11] Rust KF(2010)Childhood obesity, other cardiovascular risk factors, and premature death N Engl J Med 362 485-112
  • [12] Byrd-Holt DD(2000)Body index measurements in 1996–7 compared with 1980 Arch Dis Child 82 107-502
  • [13] de Man SA(1972)Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge Clin Chem 18 499-27
  • [14] Andre JL(2003)Sterftekansen en doodsoorzaken van niet-Westerse allochtonen CBS bevolkingstrends 2003 12-1566
  • [15] Bachmann H(2003)American heart association guidelines for primary prevention of atherosclerotic cardiovascular disease beginning in childhood Circulation 107 1562-e503
  • [16] de Vegt F(2005)Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents Pediatrics 115 e500-643
  • [17] Dekker JM(2000)Obesity as a medical problem Nature 404 635-347
  • [18] Jager A(2009)Prevalence of pre-diabetes and its association with clustering of cardiometabolic risk factors and hyperinsulinemia among U.S. adolescents: national health and nutrition examination survey 2005–2006 Diab Care 32 342-142
  • [19] Faerch K(2009)Non-high-density-lipoprotein cholesterol and cardiovascular risk factors among adolescents with and without impaired fasting glucose Appl Physiol Nutr Metab 34 136-3159
  • [20] Vaag A(2003)The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study Diab Care 26 3153-419